Introduction
============

Fibrous histiocytomas can be classified as benign and malignant. Benign fibrous histiocytomas (BFHs) can be further sub-divided by tissue of origin, either dermal or deep (subcutaneous). Cutaneous benign fibrous histiocytoma, or dermatofibroma, is localized to the dermis and characterized by an assortment of spindle and/or rounded cells. [@BR0568-1] It is a common lesion seen in many age groups, with predominance in the 3rd and 4th decades of life, and gender distribution varying by population. [@BR0568-1] The majority of lesions are found on the extremities, with lesions rarely arising on the face. [@BR0568-1] Clinically, BFHs present as single, round lesions, appearing reddish early on, and transitioning to more brown or skin-colored with time. They are moderately well circumscribed, and produce the characteristic "dimpling" sign when squeezed between the examiners fingers. [@BR0568-1] Benign fibrous histiocytomas have a variable immunohistochemical profile and multiple histologic subtypes: aneurysmal, epithelioid, cellular, angiomatoid, etc. These lesions are considered benign, and tend to recur only with incomplete excision. [@BR0568-1] Deep BFHs generally involve subcutaneous tissue, and affects adults over 25 years, with a mean age of 40 years. [@JR0568-2] [@JR0568-3] Similar to BFHs, the majority of deep BFHs are on the extremities, but may also occur in the head and neck region. [@JR0568-2] Clinically, deep BFH lesions are seen as painless, slowly enlarging masses, and are more well circumscribed/encapsulated than the cutaneous form. [@JR0568-2] Metastasis has yet to be reported.

Malignant fibrous histiocytoma (MFH) was first described by O\'Brien and Stout in 1964. [@JR0568-4] Malignant fibrous histiocytoma was historically thought to be the malignant and undifferentiated counterpart of the BFH. Recent advances have changed our understanding of their cell origin, resulting in reclassification as undifferentiated pleomorphic sarcoma. However, many clinicians continue to use the broader term MFH. In adults, MFH is the second most common soft tissue sarcoma (STS), with an incidence of 0.88 cases per 100,000 annually. [@JR0568-5] It occurs more commonly in men (2:1, Male:Female), and the incidence increases with age. [@JR0568-5] [@JR0568-6] Malignant fibrous histiocytoma is one of the most commonly diagnosed sarcomas in patients with prior radiation exposure in the head or neck region. [@JR0568-7] The most common locations of these tumors in order are the head and neck, the extremities, the trunk, and the retroperitoneum. [@JR0568-8] Those occurring on the head and neck might exhibit a more aggressive course; one study reported a 5-year overall survival of 48% for patients with head and neck tumors compared with 77% for patients with trunk or extremity tumors. [@JR0568-9]

The clinical presentation typically involves a painless, enlarging nodule that can become painful if enlarging rapidly. [@JR0568-8] Identification often involves histologic and immunohistochemical evaluations. Treatment typically involves wide local excision, en bloc resection with 2cm margins of uninvolved tissue, or Mohs surgery. [@JR0568-8] [@JR0568-10] However, local recurrence rates are high, ranging from 25 to 75%. [@JR0568-5] [@JR0568-8] Additional treatment with adjuvant radio- or chemotherapy should be considered on an individual case basis. [@JR0568-11]

Malignant or benign fibrous histiocytoma involvement of the tongue is considerably rare, and offers additional symptomatology, such as difficulty speaking or swallowing. [@JR0568-12] [@JR0568-13] Our review of the available literature identified 20 published cases. Thus, the present review serves to comprehensively describe previously published cases of BFH and MFH involving the tongue and aggregate information involving the rare presentation of this tumor entity.

Review of the Literature
========================

Literature Search
-----------------

The National Library of Medicine PubMed database was searched for articles discussing dermatofibromas and dermatofibrosarcomas, or fibrous histiocytomas affecting the tongue. The following search terms were used: *tongue* and *lingual* combined with *undifferentiated pleomorphic sarcoma* , *dermatofibroma* , *fibrous histiocytoma* , and *dermatofibrosarcoma* . The articles were screened for relevance based on title and abstract. Potentially relevant articles were subsequently reviewed in full-text for final inclusion decision. Additionally, the references of each included article were screened for additional potentially relevant articles. Potentially relevant articles were case reports or case series or studies discussing fibrous histiocytomas affecting the tongue that described patient-level data and met the inclusion criteria. The inclusion criteria were: articles discussing the clinical course of cases of lingual fibrous histiocytoma, including presentation, diagnostic workup, treatment, and outcome. Articles were excluded if they did not contain patient-level data and/or original data (that is, literature reviews), did not pertain to the present topic, or were published in a language other than English. Of the included articles, patient-level data was extracted and discussed in the present review.

The search of the PubMed database through September 2016 ( [Fig. 1](#FI0568-1){ref-type="fig"} ) returned 234 articles. Screening by title and abstract left 18 potentially relevant articles for full-text review. Upon full-text review, two studies were excluded for having diagnoses that did not meet the inclusion criteria (that is, a diagnosis other than fibrous histiocytoma). Two additional articles were found to meet the inclusion criteria upon the screening of the article citations. Ultimately, a group of 18 articles, describing 20 cases, was included in this review. These cases included 15 malignant [@JR0568-12] [@JR0568-14] [@JR0568-15] [@JR0568-16] [@JR0568-17] [@JR0568-18] [@JR0568-19] [@JR0568-20] [@JR0568-21] [@JR0568-22] [@JR0568-23] [@JR0568-24] [@JR0568-25] and 5 benign [@JR0568-13] [@JR0568-26] [@JR0568-27] [@JR0568-28] [@JR0568-29] fibrous histiocytomas affecting the tongue.

![Systematic search and review strategy of the PubMed database. The initial search returned 234 articles. After screening the titles and abstracts, 18 articles were reviewed in full-text for final inclusion. Of these, two articles were excluded for not meeting the inclusion criteria. Two additional articles were included after screening the references of the included cases. A final group of 18 articles describing 20 cases was included in this review.](10-1055-s-0037-1602819-i0568-1){#FI0568-1}

Clinical Presentation
---------------------

The demographic profiles of fibrous histiocytomas, summarized in [Table 1](#TB0568-1){ref-type="table"} , were markedly different between the benign and malignant tumors. The mean patient age for BFH was 25.8 (range, 8--51) years, whereas MFH appears to affect an older population, with a mean age of 46.6 (range, 0.4--72) years. Additionally, the benign form reportedly had a marked predilection for females, with 80.0% of cases involving female patients versus 40.0% of cases involving female patients in the malignant form.

###### Patient Demographics and Clinical Presentation of Fibrous Histiocytoma of the Tongue

  Characteristic                                                Benign Fibrous Histiocytoma, n (%)   Malignant Fibrous Histiocytoma, n (%)
  ------------------------------------------------------------- ------------------------------------ ---------------------------------------
  **Demographics**                                                                                   
   Mean, range of age (years)                                   25.8, 8--51                          46.6, 0.4--72
   Female                                                       4 (80.0)                             8 (40.0)
   Male                                                         1 (20.0)                             9 (60.0)
  **Presentation**                                                                                   
   Mean, range of tumor diameter (cm)                           2.5, 0.4--5.5                        2.9, 1--5.6
   Duration of symptoms (months)                                5.0                                  3.6
   Painful\*                                                    0 (0.0)                              2 (13.3)
   Firm\*                                                       4 (80.0)                             2 (13.3)
   Epithelial disruption (gray/white, ulcerated, fungating)\*   0 (0.0)                              8 (53.3)
  **Location**                                                                                       
   Anterior                                                     1 (20.0)                             2 (13.3)
   Posterior                                                    0 (0.0)                              3 (20.0)
   Left lateral                                                 2 (40.0)                             6 (40.0)
   Right lateral                                                1 (20.0)                             3 (20.0)
   Base                                                         1 (20.0)                             2 (13.3)
   Dorsal                                                       2 (40.0)                             3 (20.0)
   Ventral                                                      1 (20.0)                             0 (0.0)
   Unspecified                                                  0 (0.0)                              2 (13.3)

Notes: \*Presence/absence of each finding not reported in all cases. Percent is out of total number of cases. Total benign fibrous histiocytoma cases: *n*  = 5. Total malignant fibrous histiocytoma cases: *n*  = 15.

The cases generally presented as a gradually progressive, painless nodule on the tongue with a firm and/or rubbery, elastic texture. The benign cases demonstrated no overt epithelial disruption. The malignant tumors were slightly larger than the benign ones, with an average diameter of 2.92 cm and 2.48 cm respectively. The malignant cases often presented as gray/white, ulcerated, or fungating lesions ( *n*  = 8; 53.3%) that may have affected tongue movement ( *n*  = 2; 13.3%). Single cases reported physiologic effects of the tumor, such as dysphagia, hoarseness, and sore throat. Cervical lymphadenopathy was not reported in any benign or malignant cases. However, constitutional symptoms such as weight loss and fever were reported in single cases. The duration of the symptoms was 3.6 (range, 0--12) months on average for the malignant cases. Benign cases presented later, at 5.0 (range, 2--7) months.

Workup
------

Blood chemistry values were rarely reported and otherwise generally unremarkable. Diagnostic imaging studies were reported in two malignant cases, and minimally discussed. The diagnosis was made with histopathologic evaluation in all cases. Tissue was usually procured through excisional or incisional biopsy, though one case employed the use of fine needle aspiration (FNA). Histopathological evaluation was the primary diagnostic modality; the most commonly observed histopathologic features are summarized in [Table 2](#TB0568-2){ref-type="table"} . On the histopathologic evaluation ( [Fig. 2](#FI0568-2){ref-type="fig"} ), BFH lesions were predominantly composed of plump spindle-shaped fibroblasts arranged in a storiform pattern. Scattered histiocytes were present and demonstrated pale and/or round nuclei, though occasional mitotic figures were present in two cases. The MFH cases exhibited pleomorphic cells that were haphazardly arranged with occasional storiform foci. Mitotic figures were present in the majority of cases ( *n*  = 8 of 13, 61.5%). The spindle-shaped fibroblasts cells were reported to have ovoid, elongated nuclei with dense clumped chromatin. The histiocyte-like cells were hyperchromatic with lobulated nuclei and a granular or foamy cytoplasm. Multinucleated giant cells were present in 8 cases (61.5%), and exhibited pleomorphic nuclei.

![Benign fibrous histiocytoma histology (a-b) showing spindle-shaped fibroblasts arranged in a storiform pattern with scattered histiocytes. Malignant fibrous histiocytoma histology (c-d) demonstrates spindle-shaped to pleomorphic cells haphazardly arranged with occasional mitotic figures (Courtesy of Dr. Paul L. Haun, M.D.).](10-1055-s-0037-1602819-i0568-2){#FI0568-2}

###### Histologic characteristics of fibrous histiocytoma of the tongue

  Characteristic                       Benign Fibrous Histiocytoma, n (%)   Malignant Fibrous Histiocytoma, n (%)
  ------------------------------------ ------------------------------------ ---------------------------------------
  **Histologic finding\***                                                  
  Pleomorphic                          2 (40.0)                             8 (61.5)
  Mitotic figures                      2 (40.0)                             8 (61.5)
  Storiform pattern                    3 (60.0)                             10 (76.9)
   Spindle, fibroblast-like cells      5 (100.0)                            13 (100.0)
   Histiocyte-like cells               5 (100.0)                            12 (92.3)
   Multinucleated giant cells          0 (0.0)                              8 (61.5)
  **Immunohistochemical expression**   4 (100.0) ^†^                        6 (100.0) ^†^
   α-chymotrypsin                      1 (25.0)                             2 (33.3)
   CD34                                2 (50.0)                             0 (0.0)
   Cytokeratin                         0 (0.0)                              0 (0.0)
   Desmin                              0 (0.0)                              0 (0.0)
   Keratin                             0 (0.0)                              0 (0.0)
   S100                                0 (0.0)                              0 (0.0)
   Vimentin                            2 (50.0)                             1 (16.7)

Notes: \*Malignant fibrous histiocytoma histologic findings are shown as percent out of 13 cases with available histologic data. ^†^ Immunostain not reported in all cases. Percent positivity is out of the total number of cases with immunostain data available.

The immunohistochemistry results (summarized in [Table 2](#TB0568-2){ref-type="table"} ) were reported in 4/5 BFH and in 6/15 MFH cases, and were primarily valuable for diagnostic exclusion. The reported immunostains were as follows: α1-antitrypsin, α1-antichymotrypsin, CD117, CD31, CD34, CD68, carcinoembryonic antigen (CEA), cytokeratin, desmin, factor VIII, keratin, K ~i~ -67 protein, Leu7, S100, smooth muscle actin, and vimentin. One to two malignant and benign cases were reported to have α1-antitrypsin, α1-antichymothrypsin, CD34, CD68, smooth muscle actin, and vimentin immunoreactivity. Benign and malignant cases were both consistently negative for desmin and S100 staining.

Treatment and Outcome
---------------------

The treatment and outcomes of the included cases are summarized in [Table 3](#TB0568-3){ref-type="table"} . All BFHs were treated surgically with local excision ( *n*  = 4, 80.0%) or CO ~2~ laser excision ( *n*  = 1, 20%). The single recurrent case, initially excised with CO ~2~ laser, was treated with subsequent hemiglossectomy. No cases of benign tumors received radiation or chemotherapy. At an average follow-up of 44.6 months, all benign cases were reported to be disease free.

###### Treatment and Outcome of Fibrous Histiocytoma of the Tongue

                                       Benign Fibrous Histiocytoma, n (%)   Malignant Fibrous Histiocytoma, n (%)
  ------------------------------------ ------------------------------------ ---------------------------------------
  **Treatment**                                                             
   Resection/excision                  4 (80.0)                             4 (26.7)
   Partial/hemiglossectomy             1 (20.0)                             6 (40.0)
   Total glossectomy                   0 (0.0)                              1 (6.7)
   Neck dissection                     0 (0.0)                              4 (26.7)
   Chemotherapy                        0 (0.0)                              4 (26.7)
   Radiotherapy                        0 (0.0)                              8 (53.3)
   CO ~2~ laser excision/debulking     1 (20.0)                             2 (13.3)
  **Outcomes**                                                              
   Recurrence                          1 (20.0)                             6 (40.0)
   Disease free                        5 (100.0)                            8 (53.3)
   Death due to the disease            0 (0.0)                              7 (46.6)
   Mean, range of follow-up (months)   44.6, 1--144                         21.7, 9--37

Notes: Percent may add up to more than 100 due to patients receiving multiple treatment modalities. Reported case numbers (n) may add up to more than the total number of cases (BFH = 5; MFH = 15) due to patients receiving multiple treatment modalities.

Malignant tumors were primarily treated with surgery. Resection/excision was performed in 4 cases ( *n*  = 4; 26.7%). Partial or hemiglossectomy was performed in 6 cases ( *n*  = 6; 40.0%); Total glossectomy was performed in 1 case ( *n*  = 1; 6.7%). Neck dissection was performed in 4 (26.7%) cases to evaluate the cervical lymph nodes for possible metastasis. Adjuvant radiotherapy was administered in 8 (53.3%) cases, often for recurrent disease or for suspicion of metastasis, with various modalities: iridium or radium implant/brachytherapy, telecobalt therapy, or unspecified external beam radiotherapy, and the results varied. Adjuvant chemotherapy was administered in 4 (26.7%) cases, also often for recurrence or metastasis. Combination chemotherapy regimens included doxorubicin + dacarbazine, actinomycin D + vincristine sulfate + cyclophosphamide, or cyclophosphamide + vincristine + doxorubicin + dacarbazine (CYVADIC). Recurrence occurred in 6 (40.0%) cases. At an average follow-up of 24.1 (range, 9--37) months, 8 (53.3%) cases were disease-free. In 7 (46.6%) cases, the patients succumbed to disease at an average of 19 (range, 9--34) months. All cases are summarized in [Table 4](#TB0568-4){ref-type="table"} .

###### Case data

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Article               Age (years)\                          Tumor                                                         Size              Chief Complaint                                                            Duration of Symptoms                                          Prior radiation   Treatment                                                                                                                                                               Results                                                                        Follow-up
                        Ethnicity\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
                        Gender                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  --------------------- ------------------------------------- ------------------------------------------------------------- ----------------- -------------------------------------------------------------------------- ------------------------------------------------------------- ----------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ -------------------------------------------------------------------------------
  Chen et al 2001       16-year-old Chinese Female            MFH                                                           2 × 2.5cm         Enlarging painless swelling                                                5 days                                                        None              Hemiglossectomy with modified radial neck dissection                                                                                                                    Negative margins and nodes                                                     Free of disease at 3 years

  Geist et al 1990      60-year-old Caucasian Male            MFH in thorax, metastasis to tongue                           1.5 × 0.5cm       Progressive weakness and fatigue with painful enlarging mass in tongue     2 months of weakness and fatigue, 1--2 weeks of tongue mass   None              Doxorubicin hydrochloride and DTIC chemotherapy followed by surgical resection with adjuvant radiation for lung persistence and chemo with fludarabine for metastasis   Disease continued to spread                                                    Died of disease 16 months after presentation

  Lin et al 1994        57-year-old Taiwanese Male            MFH                                                           −                 Painful mass                                                               1 month                                                       2.5 years ago     Total glossectomy and partial mandibulectomy followed by subtotal excision with palliative chemotherapy for recurrence                                                  Recurred 6 months after primary surgery                                        Died at 26mo

  Lopez et al 2011      8-year-old Caucasian Female           BFH                                                           0.4 × 0.4cm       Asymptomatic nodule noticed by parents                                     6 months                                                      None              Excision                                                                                                                                                                Clearance                                                                      No recurrence at 3 years follow-up

  Mahajan et al 1989    28-year-old German Female             MFH                                                           −                 Pain and trismus progressing to hoarseness and decreased tongue mobility   7 months                                                      None              Neoadjuvant chemo, modified neck dissection, partial mandibulectomy, partial glossectomy, and pharyngectomy with adjuvant radiotherapy and chemotherapy                 Clearance with negative lymph nodes                                            No recurrence at 15 months

  Manni et al 1986      61-year-old Caucasian Male            MFH                                                           9 × 5 × 3cm       Progressive tongue swelling, bleeding, and swallowing difficulties         6 months                                                      None              Hemiglossectomy with supraomohyoid neck dissection                                                                                                                                                                                                     No recurrence at 2 years

  McMillan et al 1986   42-year-old Female                    MFH                                                           2.5cm             Enlarging symptomless swelling                                             8 weeks                                                       None              Excisional biopsy followed by left hemiglossectomy after histologic diagnosis                                                                                                                                                                          No recurrence at 9 months

  Pandey et al 2013     26-year-old Indian Male               BFH                                                           6 × 5cm           Slow growing mass                                                          5 months                                                      None              Excision and blunt dissection                                                                                                                                                                                                                          Disease-free at 1 month f/u

  Priya et al 2013      30-year-old Indian Female             BFH                                                           3 × 3cm           Nodular mass causing speech difficulty                                     7 months                                                      None              Excision under local anesthesia                                                                                                                                         Tongue function improvement                                                    No recurrence at 3 years

  Rapidis et al 2005    24-year-old Caucasian Male            MFH                                                           3 × 2 × 1cm       Slowly enlarging painless swelling                                         5 months                                                      None              Surgical resection with 1 cm tumor-free margins                                                                                                                                                                                                        Disease-free at 18 months

  Restrepo et al 1987   5-month-old Caucasian Male            MFH                                                           −                 Difficulty bottle feeding                                                  −                                                             None              Partial glossectomy with adjuvant iridium implants and 2 years of actinomycin D, vincristine sulfate, cyclophosphamide chemo                                            Unremarkable metastatic workup                                                 Disease free at 18 months after diagnosis (7 months after therapy completion)

  Velez et al 1986      14-year-old African American Female   Atypical FH                                                   3.2 × 2 × 0.7cm   Rapidly growing non-tender mass                                            2 weeks                                                       None              Excised with CO2 laser under general anesthesia followed by hemiglossectomy after recurrence                                                                            Local recurrence within several weeks. Tumor-free margins on hemiglossectomy   Patient died 6 months later due to Cystic Fibrosis

  Takimoto et al 1990   51-year-old Japanese Female           FH                                                            2 × 1.5 × 1cm     Sore throat with globus sensation                                          "several months"                                              None              Elliptical excision with 5 mm margins                                                                                                                                                                                                                  Asymptomatic with no evidence of recurrence at 12 years

  Young et al 1989      67-year-old Taiwanese Female          MFH                                                           −                 Rapidly growing protruding mass                                            −                                                             5 years ago       Tumor debulking by CO2 laser followed by excision with tongue flap push back reconstruction and adjuvant radiation for recurrence                                                                                                                      No evidence of recurrence at 3 years after excision

  Young et al 1989      52-year-old Taiwanese Male            MFH                                                           −                 Globus sensation                                                           −                                                             12 years ago      Tumor debulking by CO2 laser                                                                                                                                            Neck metastasis found 1 month after debulking                                  Died of disease 16 months after diagnosis

  Zapater et al 1995    71-year-old Caucasian Male            MFH                                                           4 × 2cm           Painful gum mass                                                           3 months                                                      None              Telecobaltotherapy of the tongue and oral cavity and then curietherapy on the primary lesion                                                                            No evidence of tumor macroscopically                                           Recurrence at 8 months, patient died of disease one month later

  Bras et al 1987       72-year-old Caucasian Male            MFH                                                           −                 Painless swelling                                                          3 months                                                      −                 Radium implants initially followed by local surgery and modified radical neck dissection for recurrence                                                                 Partial response, recurrence                                                   Died of disease after 12 months

  Bras et al 1987       65-year-old Caucasian Male            MFH                                                           −                 Found on follow-up from prior irradiation for SCC of the tongue            −                                                             10 years ago      Initial resection followed by surgery for local recurrence and radiotherapy + CYVADIC chemo for lung metastasis                                                                                                                                        Died of disease after 20 months

  Barnes et al 1988     21-year-old Female                    MFH                                                           3cm               Asymptomatic mass                                                          12 months                                                     None              Partial right glossectomy with right modified radical neck dissection                                                                                                   Negative lymph nodes                                                           No evidence of disease at 37 months

  Hiasa et al 1986      63-year-old Japanese Female           Right pleural MFH metastasis to the tongue and other organs   5 × 4 × 3cm       Swelling of the right edge of the tongue                                   −                                                             1 year ago        Partial resection with adjuvant radiation to primary tumor. Followed by radiation to metastases                                                                                                                                                        Died of disease at 34 months
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Abbreviations: BFH benign fibrous histiocytoma; CYVADIC, cyclophosphamide + vincristine + doxorubicin + dacarbazine; DTIC, dacarbazine; FH, fibrous histiocytoma; MFH, malignant fibrous histiocytoma; SCC, squamous cell carcinoma.

Note: - = not reported.

Discussion
==========

Benign fibrous histiocytomas of the tongue are consistent in clinical presentation and course. The mean patient age is 25.8 years, with 80% of cases affecting females. The cases presented as painless, gradually growing, firm masses. Surgical excision of benign lesions demonstrated excellent prognosis. The single case using CO ~2~ laser required subsequent hemiglossectomy due to recurrence. In early oral cancers, this modality is potentially an effective and functionally advantageous approach to therapy. [@JR0568-30] However, in the case of BFH of the tongue, incomplete resection, and thus subsequent recurrence, is of concern. Further study is warranted to validate the efficacy of the CO ~2~ laser as monotherapy for BFH of the tongue. This modality could also have use in tumor debulking, or may be indicated for smaller lesions.

Accurate histopathological diagnosis of these tumors is critical, considering the large differences in treatment and outcome, based on tumor pathology and, subsequently, malignant potential. The differential diagnosis for BFH and MFH is broad, and includes the following: fibroma, fibrosarcoma, dermatofibrosarcoma protuberans, neurofibroma, Kaposi sarcoma, among others.

Considering the high innervation, functional importance, and cosmetically sensitive nature of the tongue, tissue-preserving technique could be considered for excision of tumors in this location. Mohs micrographic surgery techniques may be of interest for BFH or MFH of the tongue. A case series of Mohs surgical excision of squamous cell carcinomas affecting the tongue demonstrated promising results, with no recurrence evident at a follow-up of 12--34 months. [@JR0568-31] If appropriate, application of this technique could reduce the need for disfiguring glossectomies. Further evaluation of its efficacy is warranted.

The current World Health Organization guidelines for tumors historically called MFH now classifies them as undifferentiated pleomorphic sarcoma. Tumors should be classified as such only after all recognizable lines of differentiation have been excluded. [@JR0568-32] The nomenclature of MFH subtypes was also changed to the following: storiform-pleomorphic MFH/undifferentiated high-grade pleomorphic sarcoma, giant cell MFH/undifferentiated pleomorphic sarcoma with giant cells, and inflammatory MFH/undifferentiated pleomorphic sarcoma with prominent inflammation. These 3 subtypes remained within the "so-called fibrohistiocytic tumors" category, while myxoid MFH/myxofibrosarcoma, now a separate entity, has been moved to the myofibroblastic tumor category. [@JR0568-2]

Final Comments
==============

The present review of the available literature returned 5 cases of BFH and 15 cases of MFH. The BFH cases demonstrated an apparent predilection for female (80.0% versus 40.0% in MFH) and younger (25.8 versus 46.6 in MFH) patients than MFH. The benign cases presented as a slowly growing, asymptomatic nodule with a firm, rubbery and elastic texture. The lesions were diagnosed by histopathologic evaluation with immunostaining used primarily for diagnostic exclusion. Of the BFH cases treated with first-line surgical excision, no recurrences were reported, whereas the case treated with initial CO ~2~ laser required subsequent hemiglossectomy for tumor recurrence.

Malignant tumors presented as gray/white, ulcerated, fungating lesions with an average diameter of 2.92 cm. A minority of cases reported physiologic effects of the tumor, including affected tongue motility, dysphagia, hoarseness, and sore throat. The histopathologic workup demonstrated pleomorphic cells with occasional storiform patterns. Mitotic figures were present, with a mix of spindle-shaped fibroblast-like cells, histiocyte-like cells, and multinucleated giant cells. The surgical treatment is first-line, and adjuvant radiotherapy may be considered. Combination chemotherapy regimens vary. Recurrence occurred in 40.0% of cases (follow-up of 24.1 months), with death due to disease in 46.6% of patients (follow-up of 19.0 months).
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